Approval · Notice of Compliance 1636 · 2004
GEN-MEDROXY: Notice of Compliance 1636
Issued April 23, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1636
- Date
- April 23, 2004
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph as requested in tpd letter regarding working paper for product monographs of non-contraceptive estrogen and estrogen/progestin products
- Therapeutic class
- Progestagen, progestational steroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-MEDROXY | Not yet assigned | — |
Medicinal ingredients
- MEDROXYPROGESTERONE ACETATE 2.5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 10 MG per TAB